• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Neuralstem settles IP suit with ReNeuron

Neuralstem settles IP suit with ReNeuron

January 28, 2011 By MassDevice staff

Neuralstem ReNeuron logos

Neuralstem Inc. (AMEX:CUR) reached a settlement in its intellectual property lawsuit against ReNeuron Ltd.

The deal closed the litigation between the two companies that began in April 2008, when Neuralstem sued ReNeuron over the alleged theft of trade secrets related to its central nervous system stem cell technology.

Neuralstem entered into a material transfer agreement with ReNeuron, a unit of Surrey U.K.-based ReNeuron Group plc (LON:RENE), in Feb. 2002. The MTA did not result in its proposed joint venture between the two companies, but Neuralstem alleged that ReNeuron filed two patents in 2005 and an investigational new drug application with the Food & Drug Administration in 2006 using IP related to the companies agreement, according to court documents filed with the U.S. District Court for Central California.

The settlement agreement between the two companies is confidential, but resolves all claims asserted by Neuralstem against ReNeuron, according to Neuralstem. The agreement stipulates that ReNeuron "immediately" compensate Neuralstem and make future milestone and royalty payments to the company "based on ReNeuron’s development of certain products at issue in the case," according to Neuralstem.

“We are pleased to have settled this dispute and that the parties have put this matter behind them,” Neuralstem CEO Richard Garr said in prepared remarks.

Back in August, Neuralstem asked the FDA for permission to begin a clinical trial of a chronic spinal injury treatment using stem cells.

Filed Under: Business/Financial News, Neurological, News Well, Stem Cells Tagged With: Neuralstem Inc., ReNeuron Ltd.

More recent news

  • Autonomix picks up key nerve ablation catheter patent
  • Affluent Medical can move to pivotal phase of artificial urinary sphincter study
  • Globus Medical announces $500M share repurchase program
  • Cook Medical warns of issue with angiographic catheter
  • Virtuoso Surgical reports first cases with robotic endoscopy system, plans FDA IDE submission

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy